Intracavitary injections of 131I – TM601 were well tolerated and up to the maximum up to the maximum planned dose . In an analysis that included all 69 patients who dose of 40 mg dose of 40 mg mCi/0.8 131I – TM601, there was a trend of improved survival with six versus three doses with a median survival of 11.9 months versus 9.1 months. Historically, this patient population would expect a median survival time of about six months from the date of recurrence have. ‘This study shows that 131I – TM601 improves survival and that up to six weekly doses is very safe,’said Dr. John Fiveash, associate professor of radiation oncology at the University said of Alabama at Birmingham and lead investigator for the study. ‘We hope to expand this research in the future to investigate the role of the peptide in patients with newly diagnosed glioma.
Two points of view Binocular vision allows us to to perceive depth and a detailed visual processing. The images projected by each eye are aligned and matched in brain regions than the visual thalamus and cortex.Immune cells which cytokine: IL-25 both Supports and boundaries Inflammatory Diseases.
IL-25 may be be’good ‘cytokines by chronic inflammatory reactions. Simultaneously, contribute to the ability of IL-25 type 2 responses to disk asthma than might to be which ‘bad’page of the cytokine.